Literature DB >> 23319255

Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.

L Deantonio1, L Masini, M Brambilla, F Pia, M Krengli.   

Abstract

BACKGROUND: Dysphagia is a complication of head and neck cancer patients undergoing radiotherapy (RT). We analysed frequency and severity of swallowing dysfunction and correlated these findings with dose-volume histograms (DVHs) of the pharyngeal constrictor muscles.
METHODS: A total of 50 patients treated by radical RT were enrolled. DVHs of constrictor muscles were correlated with acute and late dysphagia and with the items of three quality of life questionnaires.
RESULTS: Mean dose to superior and middle constrictor muscles (SCM, MCM), partial volume of SCM and MCM receiving a dose ≥ 50 Gy dose to the whole constrictor muscles ≥ 60 Gy and tumour location were associated to late dysphagia at univariate analysis. Mean dose to the MCM was the only statistically significant predictor of late dysphagia at the multivariable analysis.
CONCLUSION: The study shows a significant relationship between long-term dysphagia and mean doses to SCM, MCM, whole constrictor muscles, and oropharyngeal tumour. This finding suggests a potential advantage in reducing the RT dose to swallowing structures to avoid severe dysphagia.

Entities:  

Mesh:

Year:  2013        PMID: 23319255     DOI: 10.1007/s00066-012-0288-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

Authors:  Vincent Grégoire; Peter Levendag; Kian K Ang; Jacques Bernier; Marijel Braaksma; Volker Budach; Cliff Chao; Emmanuel Coche; Jay S Cooper; Guy Cosnard; Avraham Eisbruch; Samy El-Sayed; Bahman Emami; Cai Grau; Marc Hamoir; Nancy Lee; Philippe Maingon; Karin Muller; Hervé Reychler
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280

3.  Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck.

Authors:  Vincent Grégoire; Avraham Eisbruch; Marc Hamoir; Peter Levendag
Journal:  Radiother Oncol       Date:  2006-04-17       Impact factor: 6.280

4.  Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer.

Authors:  Elizabeth J Franzmann; Donna S Lundy; Andre A Abitbol; W Jarrard Goodwin
Journal:  Head Neck       Date:  2006-08       Impact factor: 3.147

5.  Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.

Authors:  Avraham Eisbruch; Hyungjin M Kim; Felix Y Feng; Teresa H Lyden; Marc J Haxer; Mary Feng; Frank P Worden; Carol R Bradford; Mark E Prince; Jeffrey S Moyer; Gregory T Wolf; Douglas B Chepeha; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-17       Impact factor: 7.038

6.  Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Authors:  Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

7.  Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.

Authors:  Shreerang A Bhide; Sarah Gulliford; Rehan Kazi; Iman El-Hariry; Kate Newbold; Kevin J Harrington; Christopher M Nutting
Journal:  Radiother Oncol       Date:  2009-10-31       Impact factor: 6.280

Review 8.  Dysphagia in head and neck cancer patients treated with chemoradiotherapy.

Authors:  Nele Platteaux; Piet Dirix; Eddy Dejaeger; Sandra Nuyts
Journal:  Dysphagia       Date:  2009-08-27       Impact factor: 3.438

9.  Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.

Authors:  Jimmy J Caudell; Philip E Schaner; Ruby F Meredith; Julie L Locher; Lisle M Nabell; William R Carroll; J Scott Magnuson; Sharon A Spencer; James A Bonner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-07-16       Impact factor: 7.038

10.  Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.

Authors:  Piet Dirix; Sarah Abbeel; Bianca Vanstraelen; Robert Hermans; Sandra Nuyts
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-24       Impact factor: 7.038

View more
  22 in total

1.  (Chemo)radiotherapy after laser microsurgery and selective neck dissection for pN2 head and neck cancer.

Authors:  Hendrik Andreas Wolff; Friedrich Ihler; Nina Zeller; Christian Welz; Klaus Jung; Martin Canis; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

2.  The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma.

Authors:  H Yin; M E; H Zhang; C Wang
Journal:  Clin Transl Oncol       Date:  2017-01-13       Impact factor: 3.405

3.  Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.

Authors:  Antonin Levy; Pierre Blanchard; Sara Bellefqih; Nacéra Brahimi; Joël Guigay; François Janot; Stéphane Temam; Jean Bourhis; Eric Deutsch; Nicolas Daly-Schveitzer; Yungan Tao
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

4.  Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.

Authors: 
Journal:  Radiother Oncol       Date:  2016-02-17       Impact factor: 6.280

5.  Delineating brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm in head and neck radiotherapy: a CT-based model atlas.

Authors:  Domenico Genovesi; Francesca Perrotti; Marianna Trignani; Angelo Di Pilla; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Massimo Caulo; Massimo Savastano; Armando Tartaro; Antonio Raffaele Cotroneo; Giampiero Ausili Cèfaro
Journal:  Radiol Med       Date:  2014-08-05       Impact factor: 3.469

6.  Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.

Authors:  M Haderlein; S Semrau; O Ott; S Speer; C Bohr; R Fietkau
Journal:  Strahlenther Onkol       Date:  2014-02       Impact factor: 3.621

7.  Locally advanced verrucous carcinoma of the oral cavity: treatment using customized mold HDR brachytherapy instead of hemi-maxillectomy.

Authors:  K M J van Gestel; D J M Buurman; R Pijls; P A W H Kessler; P L A van den Ende; A L Hoffmann; E G C Troost
Journal:  Strahlenther Onkol       Date:  2013-08-22       Impact factor: 3.621

8.  Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease.

Authors:  Loredana Costa; Sara Pedretti; Federica Foscarini; Marta Maddalo; Ludovica Pegurri; Nadia Pasinetti; Roberta Cavagnini; Stefano Ciccarelli; Sandro Tonoli; Stefano Maria Magrini; Michela Buglione
Journal:  Radiol Med       Date:  2015-08-01       Impact factor: 3.469

9.  VFMSS findings in elderly dysphagic patients: our experience.

Authors:  Alfonso Reginelli; Francesca Iacobellis; Lucia Del Vecchio; Luigi Monaco; Daniela Berritto; Graziella Di Grezia; Eugenio Genovese; Melchiore Giganti; Salvatore Cappabianca
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

10.  Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma.

Authors:  Y Mukai; M Hata; K Mitsudo; I Koike; T Koizumi; S Oguri; M Kioi; M Omura; I Tohnai; T Inoue
Journal:  Strahlenther Onkol       Date:  2013-11-23       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.